Stem cell potency explained: totipotent, pluripotent, multipotent and unipotent
Potency describes how many cell types a stem cell can become. This guide covers the four levels and where MSCs sit among them.

Key takeaways.
- Potency is the range of cell types a stem cell can give rise to.
- Totipotent cells can form every cell type, including extraembryonic tissue such as the placenta.
- Pluripotent cells form all three germ layers but not extraembryonic tissue.
- Multipotent cells, such as MSCs and HSCs, form several lineages within a tissue type.
- Teratoma formation is the functional test that confirms pluripotency.
- Four Yamanaka factors reprogram adult somatic cells into induced pluripotent stem cells.
Potency is a hierarchy
Potency describes how many cell types a stem cell can give rise to. There are four levels, from widest to narrowest.
Totipotent cells can form all cell types, including extraembryonic tissues such as the placenta. Only the zygote and the earliest blastomeres have this ability. Pluripotent cells can form all three germ layers but not extraembryonic tissue. Multipotent cells form multiple lineages within a tissue type. Unipotent cells form a single lineage.
Pluripotent cells: ESCs and iPSCs
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are the pluripotent types. Pluripotency is confirmed functionally by teratoma formation. When transplanted, these cells can form a teratoma containing tissues from all three germ layers.
Three transcription factors, Oct4, Sox2 and Nanog, form the core pluripotency network. They act as an interconnected circuit that keeps the cell undifferentiated. One species difference is worth knowing: the LIF/STAT3 pathway is essential for maintaining pluripotency in mouse ESCs but plays a different role in human ESCs.
Reprogramming adult cells
In 2006, Shinya Yamanaka showed that adult somatic cells could be reprogrammed into pluripotent stem cells. He used four transcription factors: Oct4, Sox2, Klf4 and c-Myc. These are known as the Yamanaka factors, and the work received the Nobel Prize in 2012.
Where MSCs and HSCs sit
Mesenchymal stem/stromal cells (MSCs) and hematopoietic stem cells (HSCs) are multipotent. HSCs generate all blood and immune cells. MSCs are the population most studied in regenerative medicine research.
Potency is a description of biology, not of clinical benefit. Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses that clinics market.
Educational content for healthcare professionals. Not a treatment recommendation. Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses most clinics offer.
This guide covers the what and the why.
The how is taught live. The webinar and live training go deeper on:
- Sources and relative advantages of each stem cell type
- Signalling pathways that govern stem cell fate
- How cell type relates to the research questions being asked
- How to evaluate claims made about a cell product's potency
Common questions.
What is the difference between totipotent and pluripotent?
Are MSCs pluripotent?
What are the Yamanaka factors?
Sources
- Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35(2):e00191.
Keep reading.
Stem cell · 3 min read
What is a mesenchymal stromal cell (MSC)? The ISCT minimal criteria
The 2006 ISCT minimal criteria set the identity standard for mesenchymal stromal cells: three positive markers, five negative markers and trilineage differentiation.
Start the lessonStem cell · 3 min read
How are MSCs thought to work? The paracrine hypothesis
Current thinking is that MSCs act mainly by secreting signalling molecules that change the local environment, not by turning into replacement tissue.
Start the lessonStem cell · 3 min read
Where do MSCs come from? Tissue sources and autologous versus allogeneic cells
MSCs can be sourced from several tissues, from the patient or from a donor. The source and the processing shape both the product and how it is regulated.
Start the lessonReady for the hands-on detail?
Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.